Here's What Analysts Are Saying About Bristol-Myers Squibb Company (BMY)
Bristol-Myers Squibb Company (NYSE:BMY) is one of the best medical research stocks to buy according to hedge funds.
Bristol Myers Squibb Co (BMY)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Pzena Investment Management Richard S. Pzena | 17,943,503 | $967,872,552 | +21% | 2.9% |
| 2. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 17,190,560 | $927,258,806 | +16% | 0.54% |
| 3. | Marshall Wace LLP Paul Marshall And Ian Wace | 10,844,270 | $584,939,925 | +608% | 0.53% |
| 4. | Renaissance Technologies Jim Simons | 2,353,689 | $126,957,985 | -36% | 0.2% |
| 5. | 874,000 | $47,143,560 | 0.38% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $47.58 | 4,250 | $202,215.00 | 83,513 | 2025-04-25 | Filing | |
| $55.05 | 2,000 | $110,096.00 | 104,626 | 2025-02-20 | Filing | |
| $54.84 | 1,823 | $99,999.97 | 63,932 | 2025-02-14 | Filing | |
| $54.68 | 1,830 | $100,055.25 | 62,109 | 2024-11-01 | Filing | |
| $49.78 | 2,000 | $99,560.00 | 82,672 | 2023-12-05 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $47.33 | 56,000 | $2,650,480.00 | 167,379 | 2025-09-02 | Filing | |
| $44.23 | 378 | $16,718.94 | 5,066 | 2025-08-02 | Filing | |
| $38.01 | 97 | $3,701.83 | 0 | 2025-05-09 | Filing | |
| $55.62 | 700 | $38,930.50 | 11,760 | 2024-11-04 | Filing | |
| $61.25 | 17,986 | $1,101,642.50 | 27,868 | 2023-08-24 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 198,727,768 | $10,719,375,805 | 0.16% | |
| 2. | 176,825,406 | $9,537,962,416 | 0.16% | |
| 3. | 97,980,438 | $5,285,064,826 | 0.18% | |
| 4. | 75,367,653 | $4,065,331,350 | 0.26% | |
| 5. | 71,322,392 | $3,847,129,825 | 0.6% |
News See All
10 Best Medical Research Stocks to Buy According to Hedge Funds
On January 27, Sarah James, Cantor Fitzgerald analyst, appeared on CNBC’s ‘Squawk on the Street’ to talk about the healthcare insurance sector and the stocks coming under pressure.
Bristol-Myers Squibb Company (BMY) Growth Portfolio Driving Earnings Growth
Bristol-Myers Squibb Company (NYSE:BMY) is one of the best long-term stocks to invest in for retirement.
12 Best Long-Term Stocks to Invest in for Retirement
Days are gone when investors simply put money into fixed-income assets for their appealing yields, generating solid streams of income to finance a comfortable retirement.
Guggenheim Raises its Price Target on Bristol-Myers Squibb Company (BMY) to $72 and Reiterates a Buy Rating
On February 6, 2026, Guggenheim raised its price target on Bristol-Myers Squibb Company (NYSE:BMY) to $72 from $62 and reiterated a Buy rating.
10 Most Profitable Undervalued Stocks to Buy
Profitability has moved back into focus amid an environment where interest rates remain well above the levels seen for much of the past decade.
Jim Cramer Discusses Bristol Myers's (BMY) Cobenfy Drug
Bristol Myers Squibb Company (NYSE:BMY) is one of the largest pharmaceutical companies in the world. Its shares are up by 7.5% over the past year and by 15.4% year-to-date.
12 Stocks Jim Cramer Talked About
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer discussed remarks made by Republican Senator Tim Scott (R-S.C.).
Bristol-Myers Squibb Company (NYSE:BMY) Q4 2025 Earnings Call Transcript
Operator: All participants will be in listen-only mode. After today's presentation, there will be an opportunity to ask questions. Please note, today's event is being recorded.
Bristol-Myers Squibb (BMY) Poised for Upside With Registrational Data Ahead
Bristol-Myers Squibb Company (NYSE:BMY) ranks among the stocks with the lowest forward PE ratios.
Hedge Fund Resource Center Billionaire Hedge Funds
